Literature DB >> 15916848

Differential expression of G-protein coupled receptor 56 in human esophageal squamous cell carcinoma.

Neetu Sud1, Rinu Sharma, Riju Ray, Tushar Kant Chattopadhyay, Ranju Ralhan.   

Abstract

Herein, we describe the identification of GPCR56, an orphan G-protein coupled receptor, to be differentially expressed in esophageal squamous cell carcinoma. Although, GPCRs have been demonstrated to be altered in various human cancers, much is still unknown about GPCR56 expression in tumors. To evaluate the expression of these genes in esophageal tissues, we performed semi-quantitative Reverse-Transcription Polymerase Chain Reaction in ESCCs, dysplasia and matched normal esophageal epithelium. Increased transcript levels of GPCR56 were detected in 48% of ESCCs, while the adjacent non-malignant esophageal tissue did not show the expression of this transcript. Interestingly, most of the dysplastic tissues analyzed also exhibited increased expression of GPCR56 suggesting that alteration in GPCR56 expression is an early event in esophageal tumorigenesis. In depth analysis of GPCR56 in different stages of development and progression of esophageal tumorigenesis is warranted to explore its utility as potential early diagnostic marker and its function in esophageal cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 15916848     DOI: 10.1016/j.canlet.2005.03.018

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  14 in total

1.  GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis.

Authors:  Lei Xu; Shahinoor Begum; Jeremy D Hearn; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-06       Impact factor: 11.205

2.  GPR56 plays varying roles in endogenous cancer progression.

Authors:  Lei Xu; Shahinoor Begum; Marc Barry; Denise Crowley; Liquan Yang; Roderick T Bronson; Richard O Hynes
Journal:  Clin Exp Metastasis       Date:  2010-03-24       Impact factor: 5.150

3.  Characterization of GPR56 protein and its suppressed expression in human pancreatic cancer cells.

Authors:  Yue Huang; Jun Fan; Jing Yang; Guo-Zhang Zhu
Journal:  Mol Cell Biochem       Date:  2007-10-12       Impact factor: 3.396

4.  Platelet-activating factor receptor-mediated PI3K/AKT activation contributes to the malignant development of esophageal squamous cell carcinoma.

Authors:  J Chen; T Lan; W Zhang; L Dong; N Kang; S Zhang; M Fu; B Liu; K Liu; C Zhang; J Hou; Q Zhan
Journal:  Oncogene       Date:  2015-02-02       Impact factor: 9.867

Review 5.  Pathophysiological impact of the adhesion G protein-coupled receptor family.

Authors:  Jeanette M Einspahr; Douglas G Tilley
Journal:  Am J Physiol Cell Physiol       Date:  2022-07-18       Impact factor: 5.282

6.  Gene expression profile of esophageal cancer in North East India by cDNA microarray analysis.

Authors:  Indranil Chattopadhyay; Sujala Kapur; Joydeep Purkayastha; Rupkumar Phukan; Amal Kataki; Jagadish Mahanta; Sunita Saxena
Journal:  World J Gastroenterol       Date:  2007-03-07       Impact factor: 5.742

7.  Gene expression profile of human esophageal squamous carcinoma cell line TE-1.

Authors:  Hong-Xing Cai; Zheng-Qiu Zhu; Xiao-Ming Sun; Zhou-Ru Li; Yan-Bo Chen; Guo-Kai Dong
Journal:  Int J Clin Exp Med       Date:  2015-08-15

8.  Adhesion GPCRs are widely expressed throughout the subsections of the gastrointestinal tract.

Authors:  Luca Badiali; Jonathan Cedernaes; Pawel K Olszewski; Olof Nylander; Anna V Vergoni; Helgi B Schiöth
Journal:  BMC Gastroenterol       Date:  2012-09-25       Impact factor: 3.067

9.  Identifying candidate drivers of drug response in heterogeneous cancer by mining high throughput genomics data.

Authors:  Sheida Nabavi
Journal:  BMC Genomics       Date:  2016-08-15       Impact factor: 3.969

10.  The G-protein coupled receptor 56, expressed in colonic stem and cancer cells, binds progastrin to promote proliferation and carcinogenesis.

Authors:  Guangchun Jin; Kosuke Sakitani; Hongshan Wang; Ying Jin; Alexander Dubeykovskiy; Daniel L Worthley; Yagnesh Tailor; Timothy C Wang
Journal:  Oncotarget       Date:  2017-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.